Filing Details
- Accession Number:
- 0000899243-22-025826
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-08 17:20:12
- Reporting Period:
- 2022-07-06
- Accepted Time:
- 2022-07-08 17:20:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1529655 | Charles Gary Robb | C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-07-06 | 32,677 | $2.08 | 69,123 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-07-06 | 45,000 | $26.00 | 24,123 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Acquisiton | 2022-07-06 | 32,677 | $0.00 | 32,677 | $2.08 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
114,964 | 2023-01-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,814 | Indirect | Custodial Account for Child |
Common Stock | 5,814 | Indirect | Custodial Account for Child |
Common Stock | 5,814 | Indirect | Custodial Account for Child |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2022.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.00 to $26.001. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.
- Fully exercisable.